Low‐risk patients exhibited higher infiltration of favorable immune subsets, such as plasma cells, naïve B cells, and resting memory CD4+ T cells, whereas high‐risk patients exhibited a tumor‐promoting immune signature, enriched for M1/M2 macrophages and CD8+ T cells. This evidence concerns the gene CD4 and neoplasm.